We’re Moving Your Greatest Idea Forward
Have an invention? Tell us about it! Please note that public disclosures such as conference abstracts and publications may preclude our ability to protect your invention. Be sure to inform OTC of any imminent or prior disclosures!
Mission
Through our partnerships with faculty, industry, entrepreneurs and investors, ensure that Duke innovations reach the marketplace for the benefit of society and to enable future investment in Duke research and innovation.
Vision
Duke will be a leader in transferring its knowledge and innovations to the worldwide community.
News
New therapy for glioma receives FDA approval, leveraging cancer research conducted at Johns Hopkins & Duke University
Drs. Darell Bigner and Hai Yan (Neurosurgery, SOM) and colleagues identified the genetic mutation targeted by this new drug. Dr. Katherine Peters (Neurosurgery, SOM) was…
Triangle Universities Startup Workshop: Academic Entrepreneurs Get an Intensive Course in Venture
What does it take to build a therapeutic or medical device startup? Duke, UNC, and NC State – with support from Alexandria Venture Investments –…
restor3d Announces Successful Closing of $70 Million Financing
restor3d is a Duke orthopedic medical device start-up spun out of the lab of Professor Ken Gall (MEMS, Pratt). DCP has participated in every round.
Read More about restor3d Announces Successful Closing of $70 Million Financing
Faculty & Innovators
We work together to augment the impact of your innovations, build connections with industrial, entrepreneurial, legal and investment resources and amplify the value and impact of your Duke innovations.
Industry & Partners
Partner with us to bring transformational ideas to the marketplace.
New Ventures
Let us help you think through the opportunity, craft a business plan, and connect with the management, mentors, and investors to make your venture a success!
Duke Capital Partners
The investment network of Duke alumni, faculty, and parents which provides its members with exciting opportunities to invest in early-stage companies with a Duke connection – and for Duke-affiliated entrepreneurs to pitch their companies for potential investment.
Translational Funds
Learn more about translational funding resources and opportunities that aim to accelerate the path from research to commercialization.
Our Technologies
Looking for cutting-edge technology? We welcome you to browse our list of available technologies from therapeutics to imaging and software and find one that will make a difference!
Resources
Bringing your innovation to the market requires a lot of resources. We are here to guide you on available resources at Duke and beyond that will help you realize your dream.
Duke Start-ups
-
Duke Start-up: Warden Bio
Warden Bio is developing novel AAV-mediated gene therapies for glycogen storage disorders (GSDs). The GSD gene therapy is based on research led by the lab of Dr. Priya Kishnani, Chen Family Distinguished Professor & Division Chief for Medical Genetics at Duke University, in close collaboration with Dr. Aravind Asokan, Professor & Director of Gene Therapy at Duke University and Co-Founder of StrideBio. Over the past three decades, Dr. Kishnani has built an interdisciplinary team with world-leading GSD expertise whose efforts are most notably demonstrated by the long-standing research and clinical experience that resulted in FDA approval of alglucosidase alfa (Myozyme/Lumizyme) as the...
Founded:
2021
Duke Inventors:
Kishnani Priya, Aravind Asokan, Sun Baodong
-
Duke Start-up: Solar Unsoiled
Solar Unsoiled is an interactive, data-driven platform to optimize global solar energy production. The company is maximizing solar energy profit and reducing financial risk using predictive models to mitigate the impact of energy losses due to dust and air pollution. Solar Unsoiled targets optimization surrounding the issue of detrimental soiling losses.
Founded:
2022
Duke Inventors:
Michael Valerino
-
Duke Start-up: Basking Biosciences Inc.
Basking Bio, founded by endovascular neurosurgeon and research scientist, Shai Nimjee, is developing a drug-antidote pair for treatment of patients with ischemic stroke using technologies founded out of Duke Professor of Surgery, Bruce Sullenger’s Cardiovascular Biology Lab. Basking Biosciences is developing the only reversible anti-thrombotic therapeutic to treat ischemic stroke. Founded based on IP licensed from Duke and Ohio State Universities, DTRI-031, Basking’s lead compound, leverages the proven aptamer technology platform developed in founder Bruce Sullenger’s lab at Duke to create a highly specific inhibitor of Von Willebrand Factor (VWF) and a paired reversal agent. This paired therapy enables rapid...
Founded:
2020
Duke Inventors:
Bruce Sullenger , Shai Nimjee
Events
-
Chain Reaction Innovations is Recruiting for Cohort 9
Chain Reaction Innovations (CRI) is a 2-year fellowship program at Argonne National Laboratory for innovators focused on clean energy tech.
September 4 @ 8:00 am
OnlineInvented at Duke 2024
The 6th Invented at Duke, a special Centennial edition of the annual celebration and showcase of Duke inventors and inventions.
November 20 @ 4:30 pm
Penn Pavilion